
Gen Nex Formulations Private Limited
About Gen Nex Formulations Private Limited
Data last updated:
Gen Nex Formulations Private Limited is a private limited company based in Rourkela, Odisha, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 14 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24232OR2010PTC012803. Its GSTIN is 10AAECG0475E1Z8 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sushil Kumar (Managing Director) and Bedraj Banktesh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 364/186/4 At – Bankia P.O. – Luhakera, Rourkela, Odisha, India – 769009.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.76 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹3,133 (net margin 0.3%) and EBITDA of ₹4,430 (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gen Nex Formulations Private Limited's registered office is in Rourkela, Odisha. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. – 364/186/4 At – Bankia P.O. – Luhakera, Rourkela, Odisha, India – 769009
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Gen Nex Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gen Nex Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Gen Nex Formulations Private Limited, buy the company report.
Financials of Gen Nex Formulations Private Limited
FY 2025 filings availableGen Nex Formulations Private Limited reported revenue of ₹11.76 Lakh (down 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 21% fall in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,430 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,133 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gen Nex Formulations Private Limited, buy the company report.
Board of directors of Gen Nex Formulations Private Limited
Gen Nex Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushil Kumar | Managing Director | 14 Dec 2010 | 15 Years 11 Months | Current |
| Bedraj Banktesh | Director | 14 Dec 2010 | 15 Years 11 Months | Current |
Peer comparison
Gen Nex Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pail Pharma Private Limited | ₹12 Lakh (FY 2024) | Uttar Pradesh, India | ||||
| Gen Nex Formulations Private Limitedthis company | ₹11.76 Lakh (FY 2025) | ₹3,133 | 0.3% | -21.0% | Rourkela, Odisha, India | |
| Corelife Pharma Private Limited | ₹11.56 Lakh (FY 2020) | -26.0% | Chennai, Tamil Nadu, India | |||
| Manfred Pharmaceuticals Private Limited | ₹11.51 Lakh (FY 2025) | 24.0% | Kolhapur, Maharashtra, India |
To see the full peer comparison of Gen Nex Formulations Private Limited, buy the company report.
Shareholding
The shareholding of Gen Nex Formulations Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Gen Nex Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gen Nex Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gen Nex Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gen Nex Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECG0475E1Z8 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gen Nex Formulations Private Limited, buy the company report.
Recent activity
Gen Nex Formulations Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Bedraj Banktesh was appointed as Director on 14 Dec 2010.
Frequently asked questions
Gen Nex Formulations is an active private limited company based in Rourkela, Odisha, India. The company works in other wholesale, within the trading industry. It was incorporated on 14 December 2010 (16+ years old) and is registered under CIN U24232OR2010PTC012803.
Gen Nex Formulations has 2 current directors:
- Sushil Kumar - Managing Director
- Bedraj Banktesh - Director
The latest financial statements of Gen Nex Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gen Nex Formulations is 10AAECG0475E1Z8, registered in Bihar.
The CIN (Corporate Identification Number) of Gen Nex Formulations is U24232OR2010PTC012803. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gen Nex Formulations was incorporated on 14 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Gen Nex Formulations by revenue are Pail Pharma Private Limited, Corelife Pharma Private Limited, Manfred Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Bedraj Banktesh was appointed as Director on 14 Dec 2010. Sushil Kumar was appointed as Managing Director on 14 Dec 2010.
The registered office of Gen Nex Formulations is at Plot No. – 3641864 At – Bankia P.O. – Luhakera, Rourkela, Odisha, India – 769009.
Gen Nex Formulations operates in the trading industry, in the other wholesale segment.
The compliance status of Gen Nex Formulations is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.

